MICCAI 2000: Medical Image Computing and Computer-Assisted Intervention – MICCAI 2000 pp 338-347 | Cite as
Local Integration of Commercially Available Intra-operative MR-scanner and Neurosurgical Guidance for Metalloporphyrin-Guided Tumor Resection and Photodynamic Therapy
Conference paper
Abstract
We have locally integrated a commercial intra-operative MR-scanner and neurosurgical guidance system in order to conduct a clinical trial testing for improvement in glioma resection following administration of either of two metalloporphyrin drugs, XcytrinTM or LutrinTM (Pharmacyclics Inc., Sunnyvale, CA). Like other porphyrins, these two drugs have been shown to bind preferentially to tumor. The metal in Xcytrin is gadolinium. It should enhance intra-operative MR-scans taken during tumor resection. This would overcome problems of non-specific MR-enhancement caused by intra-operative contrast leakage from the vascular compartment. Both drugs provide fluorescence contrast in the presence of 450 nm wavelength light. Intra-operative fluorescence contrast should facilitate Lutrin photodynamic therapy administration to otherwise invisible glioma residual in the walls of the resection cavity. The metal in Lutrin is Lutetium. When illuminated with 732nm wavelength light, Lutrin causes tumor death via release of singlet oxygen (i.e., photodynamic therapy).
Keywords
Photodynamic Therapy Vascular Compartment Resection Cavity Contrast Leakage Therapy Administration
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Download
to read the full conference paper text
References
- 1.Albert, F.K., Forsting, M., Sartor, K., Adams, H.P., Kunze, S.: Early postoperative magnetic resonance imaging after resection of malignant glioma: Objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 34, 45–60 (1994)CrossRefGoogle Scholar
- 2.Callahan, D.E., Forte, T.M., Afzal, S.M., Deen, D.F., Kahl, S.B., Bjornstad, K.A., Bauer, W.F., Blakely, E.A.: Boronated protoporphyrin (BOPP): localization in lysosomes of the human glioma cell line SF-767 with uptake modulated by lipoprotein levels. Int. J. Radial Oncol. Biol. Phys. 45, 761–771 (1999)CrossRefGoogle Scholar
- 3.Cubeddu, R., Canti, G., Taroni, P., Valentini, G.: Study of porphyrin fluorescence in tissue samples of tumour-bearing mice. J. Photochem. Photobiol. B 29, 171–178 (1995)CrossRefGoogle Scholar
- 4.Damadian, R.: Tumor detection by nuclear magnetic resonance. Science 171, 1151–1153 (1971)CrossRefGoogle Scholar
- 5.Dean, D., Kamath, J., Duerk, J.L., Ganz, E.: Validation of Object-induced MR Distortion Correction for Frameless Stereotactic Neurosurgery. IEEE Trans. Med. Img. 17, 810–816 (1998)CrossRefGoogle Scholar
- 6.Forsting, M., Albert, F.K., Kunze, S., Adams, H.P., Zenner, D., Sartorm, K.: Extirpation of glioblastomas: MR and CT follow-up of residual tumor and regrowth patterns. AJNR Am. J. Neuroradiol. 14, 77–87 (1993)Google Scholar
- 7.Gering, D., Nabavi, A., Kikinis, R., Grimson, W.E.L., Hata, N., Everett, P., Jolesz, F., Wells III, W.: An Integrated Visualization System for Surgical Planning and Guidance using Image Fusion and Interventional Imaging. In: Taylor, C., Colchester, A. (eds.) MICCAI 1999. LNCS, vol. 1679, pp. 809–819. Springer, Heidelberg (1999)CrossRefGoogle Scholar
- 8.Grossweiner, L.I., Bilgin, D., Berdusis, P., Mody, T.D.: Singlet Oxygen Generation by Metallotexaphyrins. Photobiol. Photochem. 70, 138 (1999)CrossRefGoogle Scholar
- 9.Hall, W.A., Liu, H., Martin, A.J., Pozza, C.H., Maxwell, R.E., Truwit, C.L.: Safety, efficacy, and functionality of high-field strength interventional magnetic resonance imaging for neurosurgery [In Process Citation]. Neurosurgery 46, 632–641 (2000); discussion 641–2Google Scholar
- 10.Hammer-Smith, M.J., Ghahranmaniou, M., Berns, M.W.: Photodynamic activity of Lutetium-Texaphyrin in a mouse tumor system. Lasers in Surg. & Med. 24, 276–284 (1999)Google Scholar
- 11.Hebeda, K., Saarnak, A., Olivo, M., Sterenborg, H.J., Wolbers, J.G.: 5-Aminolevulinic acid induced endogenous porphyrin fluorescence in 9L and C6 brain tumours and in the normal rat brain. Acta Neurochir (Wien) 140, 503–512 (1998)CrossRefGoogle Scholar
- 12.Knauth, M., Wirtz, C.R., Tronnier, V.M., Aras, N., Kunze, S., Sartor, K.: Surgically induced intracranial contrast enhancement: Potential source of diagnostic error in intraoperative MR imaging. AJNR Am. J. Neuroradiol. 20, 1547–1553 (1999)Google Scholar
- 13.Lewin, J.S.: Interventional MR Imaging: Concepts, Systems, and Applications in Neuroradiology. AJNR Am. J. Neuroradiol. 20, 735–748 (1999)Google Scholar
- 14.Maurer, C.R.J., Hill, D.L., Martin, A.J., Liu, H., McCue, M., Ruekert, D., Lloret, D., Hall, W.A., Maxwel, R.E., Hawkes, D.J., Truwit, C.L.: Investigative of intraoperative brain deformation using a 1.5-T interventional MR system: Preliminary results. IEEE Trans. Med. Img. 17, 817–825 (1998)CrossRefGoogle Scholar
- 15.Miller, R.A., Woodburn, K., Fan, Q., Renschler, M.F., Sessler, J.L., Koutcher, J.A.: In vivo animal studies with gadolinium (III) texaphyrin as a radiation enhancer. Int. J. Radiat. Oncol. Biol. Phys. 45, 981–989 (1999)CrossRefGoogle Scholar
- 16.Noske, D.P., Wolbers, J.G., Sterenborg, H.J.C.M.: Photodynamic therapy of malignant glioma. Clin. Neurol. Neurosurg. 93, 293–307 (1991)CrossRefGoogle Scholar
- 17.Renschler, M., Yuen, A.R., Panella, T.J., Wieman, J., Dougherty, S., Esserman, L., Panjehpour, M., Taber, S.W., Fingar, V.H., Lowe, E., Engel, J.S., Lum, B., Woodburn, K.W., Cheong, W.-F., Miller, R.A.: Photodynamic therapy trials with lutetium texaphyrin (Lu-Tex) in patients with locally recurrent breast cancer. In: Dougherty, T.J. (ed.) Optical Methods for Tumor Treatment and Detection, vol. 3247, pp. 35–39. SPIE, Bellingham (1998)Google Scholar
- 18.Rosenthal, R.I., Nurenberg, P., Becerra, C.R., Frenkel, E.P., Carbone, D.P., Lum, B.L., Miller, R., Engel, J., Young, S., Miles, D., Renschler, M.F.: A phase I single-dose trial of gadolinium enhancing Texaphyrin (Gd-Tex), a tumor selective radiation sensitizer detectable by magnetic resonance imaging. Clin. Cancer Res. 5, 739–745 (1999)Google Scholar
- 19.Sessler, J.L., Dow, W.C., O’Connor, D.O., Harriman, A., Hemmi, G., Mody, T.D., Miller, R.A., Qing, F., Springs, S., Woodburn, K., Young, S.W.: Biomedical applications of lanthanide(III) texaphyrins Lutetium(III) texaphyrins as potential photodynamic therapy photosensitizers. J. Alloys & Compounds 249, 146–152 (1997)CrossRefGoogle Scholar
- 20.Shibata, Y., Matsumura, A., Yoshida, F., Yamamoto, T., Nakai, K., Nose, T., Sakata, I., Nakajima, S.: Cell cycle dependency of porphyrin uptake in a glioma cell line. Cancer Letter 129, 77–85 (1998)CrossRefGoogle Scholar
- 21.Stammer, W., Stocker, S., Wagner, S., Stepp, P.H., Fritsch, C., Goetz, C., Goetz, A.E., Kiefmann, R., Reulen, H.J.: Intraoperative detection of malignant gliomas by 5-aminolevulinic acid- induced porphyrin fluorescence. Neurosurgery 42, 518–525 (1998)Google Scholar
- 22.Sutherland, G.R., Taro, K., Louw, D., Hoult, D.I., Tomanek, B., Saunders, J.: A mobil high-field magnetic resonance system for neurosurgery. J. Neurosurg. 91, 804–813 (1999)CrossRefGoogle Scholar
- 23.Tovi, M., Lilja, A., Bergstrom, A.M., Ericsson, A., Bergstrom, K., Hartman, M.: Delineation of gliomas with magnetic resonance imaging using Gd-DTPA in comparison with computed tomography and positron emission tomography. Acta Radiol. 31, 417–429 (1990)Google Scholar
- 24.Tynninen, O., Aronen, H.J., Ruhala, M., Paetau, A., Von Boguslawski, K., Salonen, O., Jaaskelainen, J., Paavonen, T.: MRI enhancement and microvascular density in gliomas. Correlation with tumor cell proliferation. Invest. Radiol. 34, 427–434 (1999)CrossRefGoogle Scholar
- 25.Viala, J., Vanel, D., Meingan, P., Lartigau, E., Carde, P., Renschler, M.: Phases IB and II multidose trial of gadolinium Texaphyrin, a radiation sensitizer detectable at MR imaging: Preliminary results in brain metastases. Radiology 212, 755–759 (1999)Google Scholar
- 26.Wirtz, C.R., Knauth, M., Bonsanto, M.N., Sartor, K., Kunze, S., Tronnier, V.M.: Clinical evaluation and follow-up results for intraoperative magnetic resonance imaging in neurosurgery. Neurosurgery 46, 1112–1122 (2000)CrossRefGoogle Scholar
- 27.Woodburn, K.W., Fan, Q., Miles, D.R., Kessel, D., Luo, Y., Young, S.W.: Localization and efficacy analysis of the phototherapeutic lutetium texaphyrin (PCI-0123) in the murine EMT6 sarcoma model. J. Photochem. Photobiol. 65, 410–415 (1997)CrossRefGoogle Scholar
- 28.Woodburn, K.W., Qing, F., Kessel, D., Luo, Y., Young, S.W.: Photodynamic therapy of B16F10 murine melanoma with lutetium texaphyrin. J. Invest. Dermatol. 110, 746–751 (1998)CrossRefGoogle Scholar
- 29.Young, S.W., Qing, F., Harriman, A., Sessler, J.L., Dow, W.C., Mody, T.D., Hemmi, G.W., Hao, Y., Miller, R.A.: Gadolinium(III) texaphyrin: a tumor selective radiation sensitizer that is detectable by MRI. Proc. Natl. Acad. Sci. USA 93, 6610–6615 (1996)CrossRefGoogle Scholar
Copyright information
© Springer-Verlag Berlin Heidelberg 2000